Case Study: Funded vs. Unfunded Buy-Sell: Same Agreement, Very Different Outcomes

Funded vs. Unfunded Buy-Sell

Same agreement, very different outcomes. A simple two-shareholder case study illustrating how identical buy-sell provisions can produce radically different outcomes depending on whether liquidity is pre-funded.

About This Case

In closely held, high-value businesses, shareholders' agreements are often drafted with significant legal care, but far less attention is paid to whether their most critical obligations are economically fundable when triggered. This case study and accompanying checklist examine the practical difference between a buy-sell provision that exists only on paper and one that is supported by permanent, scalable capital. Using a simple two-shareholder example, the analysis illustrates how identical agreements can produce radically different outcomes depending on whether liquidity is pre-funded using permanent life insurance. The objective is not to critique legal drafting, but to highlight a recurring planning gap: agreements answer what should happen; funding determines whether it actually can.

The Setup

Company: privately held operating company. <strong>Shareholders: two equal partners (50/50). Enterprise value (Year 0): $20 million, growing to $40 million over fifteen years. Shareholders' agreement: mandatory buy-sell on death at fair market value. The agreement is professionally drafted and identical in both scenarios. The only difference is how, or whether, the obligation is funded.

Scenario A — Unfunded Buy-Sell

At death (Year 15). Company value $40 million. Deceased shareholder's interest $20 million. Required buyout: $20 million in cash. There is no dedicated funding in place. The surviving shareholder and the company are forced to choose among poor options.

Option 1: corporate borrowing. Significant leverage added to the balance sheet. Lender covenants restrict growth and distributions. The surviving shareholder assumes financial stress they did not plan for.

Option 2: share redemption from corporate cash. Working capital is impaired. Growth initiatives are delayed or cancelled. Operational risk increases.

Option 3: negotiated discount with the estate. The estate receives less than fair value. Family dissatisfaction and reputational damage follow. Legal tension persists despite a signed agreement.

Outcome: The agreement technically functions. The business is financially weakened. The relationship between shareholders' families is strained. The surviving partner inherits risk, not just control. The agreement worked on paper, but not in practice.

Scenario B — Properly Funded Buy-Sell Using Whole Life Insurance

Pre-planning structure. Insurance type: participating whole life. Ownership: cross-owned or corporately owned, aligned to the agreement. Initial death benefit: $10 million per shareholder. Design: growing death benefit aligned with business value growth.

Over fifteen years, the death benefit grows to $20 million per shareholder, and cash values accumulate as a secondary balance-sheet asset.

At death (Year 15). Company value $40 million. Required buyout $20 million. Insurance proceeds available $20 million. Insurance proceeds fund the buy-sell immediately. The estate receives full, fair value in cash. The surviving shareholder retains 100 percent control. The company's operations continue uninterrupted.

Outcome: No borrowing. No forced redemptions. No renegotiation. No family conflict. The agreement functions exactly as intended, automatically.

What the Case Actually Shows

The difference was not legal sophistication. It was capital certainty. The funded structure removed timing risk, liquidity risk, relationship risk, and business risk. This is why high-quality shareholders' agreements are capital plans, not just legal documents.

Audit Checklist for Owners and Advisors

This checklist can be used annually or at any major valuation inflection point.

A. Agreement Mechanics

Is there a mandatory buy-sell on death (not optional)? Is the valuation mechanism clear and current? Does the agreement specify who buys the shares (company versus shareholders)? Is the payment timing defined (immediate versus installment)? Are disability and incapacity clearly addressed, not just death?

B. Funding Reality

Is there dedicated funding for the buy-sell obligation? Is funding external to the operating business, not reliant on cash flow? Would the funding still work during a recession, tight credit conditions, or a sudden valuation increase? Has the funding amount been stress-tested against future growth?

C. Insurance Design

Is the insurance permanent (not expiring while the agreement survives)? Does the death benefit scale with business value growth? Is ownership aligned with the agreement structure (corporate versus cross-owned)? Are beneficiary designations coordinated with legal intent? Has tax efficiency (CDA, capital flow) been reviewed with advisors?

D. Governance and Fairness

Does the structure preserve control for surviving shareholders? Does it deliver prompt, fair value to the deceased's estate? Are non-active heirs economically protected? Does the plan minimize the risk of renegotiation under stress?

E. Review Discipline

Has the agreement been reviewed in the last two to three years? Has insurance coverage been reviewed after a major valuation increase, a new shareholder admission, a corporate reorganization, or estate planning changes?

An Agreement Without a Funding Mechanism is a Wish

A shareholders' agreement answers what should happen. Funding answers whether it actually can. At the high-net-worth level, the difference between a good agreement and a durable one is simple.

Is the obligation pre-funded with capital that grows as the business grows?

When the answer is yes, the agreement executes cleanly. When the answer is no, everything becomes negotiable, at the worst possible time.